Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2002
05/02/2002WO2001059450A3 Cells expressing zinc finger protein for drug discovery
05/02/2002WO2001057189A3 Fas pathway genes
05/02/2002WO2001055708A3 Method of processing a sample containing at least one biological element
05/02/2002WO2001055393A3 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
05/02/2002WO2001055314A3 Digestive system related nucleic acids, proteins and antibodies
05/02/2002WO2001055210A3 Human cyr61
05/02/2002WO2001053822A3 Method and device for detecting temperature-dependent parameters
05/02/2002WO2001051655A3 Oligonucleotides for amplifying and detecting bacterial genes for extracellular alkaline metalopeptidases (apr), neutral metalopeptidases (npr) and serin peptidases (spr)
05/02/2002WO2001051635A3 Novel stra6 polypeptides
05/02/2002WO2001048209A3 Genes identified as required for proliferation of e. coli
05/02/2002WO2001046394A3 Mammalian protein phosphatases
05/02/2002WO2001042494A3 Test system for detecting analytes, a method for the production thereof and its use
05/02/2002WO2001036979A3 Placental human neurokinin b precursor
05/02/2002WO2001036676A3 Security system
05/02/2002WO2001036675A3 Cd36 polymorphisms
05/02/2002WO2001034824A3 Methods and compositions comprising renilla gfp
05/02/2002WO2001034767A3 22 human secreted proteins
05/02/2002WO2001032935A3 Molecular microarrays and methods for production and use thereof
05/02/2002WO2001032919A3 Group of novel primer pairs for pcr amplification, primer pairs, gene probes and method for detecting technically genetically modified plant material
05/02/2002WO2001031028A3 Mutant luciferase
05/02/2002WO2001029071A3 Genes associated with obesity and methods for using the same
05/02/2002WO2001029070A3 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases
05/02/2002WO2001027292A3 Methods and compositions for targeting a cell
05/02/2002WO2001023538A3 Molecules for disease detection and treatment
05/02/2002WO2001019482A3 Method for sequencing reaction cleanup by constant pressure differential ultrafiltration
05/02/2002WO2001018172A3 Fibroblast growth factor-like polypeptides
05/02/2002WO2001016378A3 Chromosome-wide analysis of protein-dna interactions
05/02/2002WO2001012862A3 Compositions and methods for preparing oligonucleotide solutions
05/02/2002WO2001009381A3 Methods of nucleic acid analysis by detecting molecular binding events
05/02/2002WO2001007665A3 Sequence determination of nucleic acids using electronic detection
05/02/2002WO2001007651A3 Transposon mediated differential hybridisation
05/02/2002WO2001005803A9 NOVEL cDNAs ASSOCIATED WITH RENAL DISEASE
05/02/2002WO2001000874A3 Cancer associated antigens and uses therefor
05/02/2002WO2000079007A9 Improved methods of sequence assembly in sequencing by hybridization
05/02/2002WO2000078972A3 Regulation with binding cassette transporter protein abc1
05/02/2002WO2000077208A9 Gustatory receptors in drosophila
05/02/2002WO2000075365A9 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION
05/02/2002WO2000058524A3 Typing of human enteroviruses
05/02/2002WO2000047771A3 Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
05/02/2002WO2000044395A9 Methods and compositions for modulating fertility
05/02/2002WO2000042219A9 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
05/02/2002WO1999058683A9 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
05/02/2002US20020053093 By use of biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen
05/02/2002US20020053091 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
05/02/2002US20020052693 Pharmacophore models for, methods of screening for, and identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonists
05/02/2002US20020052482 Covalently linked oligonucleotide minor grove binder conjugates
05/02/2002US20020052477 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
05/02/2002US20020052472 ama
05/02/2002US20020052387 5-Substituted 2-aryl-4-pyrimidinones
05/02/2002US20020052334 Antisense oligonucleotide, a ribozyme, a protein, a polypeptide, an antibody, or a small molecule.
05/02/2002US20020052331 Of a capped target mRNA; oligonucleoides that inhibit protein translation directly via interference with ribosome assembly.
05/02/2002US20020052329 Lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides.
05/02/2002US20020052316 Bax-mediated apoptosis modulating reagents and methods
05/02/2002US20020052307 Laminin chains: diagnostic uses
05/02/2002US20020052043 Human G-protein coupled receptors
05/02/2002US20020052040 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
05/02/2002US20020052037 Ribozyme for use as tool in genetic engineering
05/02/2002US20020052036 Mutant B-type DNA polymerases exhibiting improved performance in PCR
05/02/2002US20020052035 18891, a novel human lipase
05/02/2002US20020052034 Peptide for use in the treatment of pancreatic defects, cardiovascular disorders, eating disorders and tumors
05/02/2002US20020052033 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
05/02/2002US20020052027 IL-17 homologous polypeptides and therapeutic uses thereof
05/02/2002US20020052016 Monitoring and controlling biocatalytic efficiency of wastewater treatment; obtain activated sludge, sample wastewater, measure concentration of interior storage particles, adjust feed nutrients
05/02/2002US20020052013 Tumour-specific P450 protein
05/02/2002US20020052005 Construction and screening of lantibody display libraries
05/02/2002US20020051995 Stacked arrays
05/02/2002US20020051994 Synthesis of oligonucleotides
05/02/2002US20020051992 Device for the analysis and monitoring of multiple samples on a solid support
05/02/2002US20020051990 Novel gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas
05/02/2002US20020051989 Nucleotide sequences for use in the detection of birds which are resistant to marek's disease
05/02/2002US20020051988 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity
05/02/2002US20020051987 Screening agglomerations for clones containing preferential enzymatic polypeptides; obtain sample of agglomeration, culture, incubate with probes, hybridize probe, detect signal, recover clone associated with signal
05/02/2002US20020051986 Method for the detection of an analyte by means of a nucleic acid reporter
05/02/2002US20020051985 Signaling composition for use in detection of preferential particles in solution
05/02/2002US20020051984 Nucleotide sequences coding cell proliferation protein; for use in the treatment of cancer, wounds, inflammation, arthritis, psoraisis, vision and cell proliferation defects
05/02/2002US20020051983 Detection of amplified products in nucleic acid assays following nuclease treatment
05/02/2002US20020051981 Monitoring particles on solid support; obtain nucleotide sequences, incubate with soild support, expose to dendrimer, monitor sample for signal
05/02/2002US20020051979 Capillary bundles for use in the detection of preferential particle in sample
05/02/2002US20020051978 Methods and compositions for the identification, assessment, prevention and therapy of human cancers
05/02/2002US20020051976 Methods and compositions for polypeptide engineering
05/02/2002US20020051975 Reporterless genosensors using electrical detection methods
05/02/2002US20020051974 Pcr assay
05/02/2002US20020051973 Oligonucleotide probes for use in the diagnosis and detection of nucleotide sequences in microarrays
05/02/2002US20020051970 Microarray-based subtractive hybridization
05/02/2002US20020051968 Viral nucleotide sequences for use in the diagnosis and detection of viral diseases; for use in generation of vaccines
05/02/2002US20020051967 Retrovirus; for use as a tool in the diagnosis and prevention of viaral diseases
05/02/2002US20020051965 Modifications of the VEGF receptor-2 protein and methods of use
05/02/2002US20020051785 HER -2/neu overexpression abrogates growth inhibitory pathways
05/02/2002US20020051782 Anti-CCR2 antibodies and methods of use therefor
05/02/2002US20020051781 CC-chemokine receptor 2 (CCR2) bound by an immunoglobulin or an antigen-binding fragment
05/02/2002US20020051777 Method of modulating cellular activity
05/02/2002US20020051733 Aluminum coated indicator will not break down upon exposure to common chemical compounds; bleachable dye changes color upon exposure to an oxidizing or bleaching sterilant
05/02/2002US20020051070 System and method for high numeric aperture imaging systems
05/02/2002US20020050456 Parylene coatings; for PCR amplification assay apparatus
05/02/2002EP1202211A2 Genomic DNA analysis computer program
05/02/2002EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression.
05/02/2002EP1201771A2 Detection and identification of human papillomavirus by PCR and type-specific reverse hybridization
05/02/2002EP1201770A2 Oligonucleotide for highly sensitive detection of hepatitis c virus and method for detection thereof
05/02/2002EP1201769A2 Gene expression monitoring using universal arrays
05/02/2002EP1201768A2 Amplification using modified primers